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Arterial plasma norepinephrine correlates to 
blood pressure in middle-aged men with 
sustained essential hypertension 
Increased plasma catecholamine levels assessed from the venous blood have been found in a 
number of studies of younger patients with essential hypertension, but hypertensive- 
normotenslve differences could not easily be demonstrated in subjects above 40 years of age. 
For several reasons, measurement of arterial plasma catecholamines may be a more sensitive 
tool for the detection of hypertensive-normotensive differences. The present study therefore 
aimed at examining both venous and arterial plasma catecholamines in a group of white men, all 
50 years of age, with never-treated, established essential hypertension (n = 61, blood pressure 
165 + 21112 + 1 mm Hg, means + SE) and comparing them with a similar group of 
normotensive men (n = 51, blood pressure 126 + l/65 + 1 mm Hg). Arterial and venous plasma 
epinephrine, heart rate, and body weight were significantly elevated in the hypertensive group. 
Plasma norepinephrine was similar between the groups in the venous blood, whereas in the 
arterial blood the values in hypertensive subjects were moderately, but significantly increased 
(p < 0.03). However, stepwise multiple regression analysis suggested arterial plasma 
norepinephrine was the only significant independent explanatory variable of raised btood 
pressure in the hypertensive group (r = 0.51, t = 4.05, p = 0.0002). Such a relationship was not 
found in the normotensive group. Thus based on measurements in arterial blood, we conclude 
that plasma norepinephrine, representing sympathetic tone, may be an important pathogenetic 
factor for high blood pressure in middle-aged men with established hypertension. (AM HEART J 
1989;116:775.) 
Sverre E. Kjeldsen, MD, Nicholas J. Schork, BA, Paul Leren, MD, and 
Ivar K. Eide, MD. Oslo, Norway, and Ann Arbor, Mich. 
Plasma norepinephrine has been taken as an index of 
sympathetic activity. Approximately 50 % of plasma 
norepinephrine in forearm venous blood comes from 
local release, mainly from the vascular sympathetic 
nerve terminals in muscle tissue.l In normotensive 
men, Wallin et al2 found a positive correlation 
between norepinephrine in forearm venous blood and 
muscle sympathetic activity. In hypertensive indi- 
viduals, forearm muscle sympathetic activity seems 
to be normal,3 and forearm venous plasma norepi- 
nephrine has been found to be unchanged in a num- 
ber of studies on hypertensive subjects4 
However, 25 of the 64 studies reviewed by 
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Goldstein4 showed significantly increased forearm 
venous plasma norepinephrine in essential hyperten- 
sion, and 52 studies reported higher levels in the hy- 
pertensive subjects. There is an increased spillover of 
norepinephrine to plasma from the heart and kidneys 
in essential hypertension.5 Venous effluents from all 
organs are completely mixed in arterial blood. Venous 
spillover of norepinephrine from the heart and kid- 
neys in essential hypertension5 is more likely to be 
detected in arterial plasma than in peripheral venous 
blood in the forearm, since the large normal uptake 
and release of norepinephrine by the forearm, both 
approximately 50 % of the arterial concentration,i 
may dampen an increased concentration from the 
arterial side. Increased arterial plasma norepineph- 
rine may then raise forearm vascular resistance in 
hypertension by cu-adrenergic stimulation.6 In addi- 
tion, measurements of peripheral venous plasma 
norepinephrine may sometimes conceal important 
hypertensive-normotensive differences.7 When the 
arterial concentrations are considerably increased, 
higher levels though reduced, may still be detectable 
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Table I. Supine blood pressure (BP), heart rate (HR), and 
other characteristics of hypertensive and normot,ensive 
groups (means ? SE) 
Hypertensirle Normotwwiue 
group group 
ill = 61) (n = 61) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Mean BP (mm Hg) 
HR (beats/min) 
Height (cm) 
Body weight (kg) 







(ml/min per 1.73 m2 
body surface) 
165 + 2 128 2 i* 
112 I 1 86 :h 14 
130 I 1 100 I 1” 
69 i 2 62 I It 
180 fr 1 179 i 1 (ns) 
86 t 2 78 T 1% 
26.6 * 0.4 24.3 i 0.3’ 
168 k 7 173 i 9 (ns) 
84 i 3 8.1 + 3 (ns) 
118 t 3 111 k 3 (ns) 
All subjects were white men, 50 years of age. 
*p < 0.001: tp < 0.01 between groups; ns, not significant 
on the forearm venous side, which may explain many 
of the controversies in the literature.4 This also im- 
plies that a negative study based on measurements of 
norepinephrine in forearm venous plasma may be of 
less value in assessing hypertensive-normotensive 
differences in sympathetic tone. 
The review by Goldstein4 claimed disappearance of 
or lower hypertensive-normotensive norepinephrine 
differences in persons aged above 40 years. However, 
the results were based on measurements of norepi- 
nephrine in peripheral venous blood. Therefore the 
present study aimed at testing our hypothesis7 that 
measurement of arterial plasma catecholamines may 
be a more sensitive tool for the detection of hyper- 
tensive-normotensive differences. We simulta- 
neously measured plasma norepinephrine in arterial 
and forearm venous blood in a fairly large group of 
white men, all 50 years of age, with never-treated, es- 
tablished essential hypertension, and in age- and 
race-matched normotensive men. Arterial and venous 
plasma norepinephrine were compared between the 
two groups; within each group, the effects of plasma 
norepinephrine and other parameters such as plasma 
epinephrine, heart rate, body weight, and electrolyte 
excretions on blood pressure were measured by step- 
wise multiple regression analysis. 
METHODS 
Hypertensive patients. Sixty-one white men, all 50 
years old with never-treated, established essential hyper- 
tension of WHO group I classification, were recruited from 
the Oslo Study of Cardiovascular Diseases, a large epide- 
miologic study in the county of Oslo, Norway.” Six to 10 
years prior to the present investigation. t.hey had systolic~ 
blood pressure below 150 mm Hg and diastolic hi,,od pre,k 
yure above 90mm Hg ( l4:i + 1 V : I mm Hg). At the time , , 
of the present study, they had stable blood pressure abovcb 
150/100 mm Hg. Further characteristics including hear1 
rate, body weight. electrolyte excretion, and creatinine 
clearance at the time of the present study are given in ‘l’a 
ble I. They had normal ocular i’undi, electrocardiograms 
(ECGs), chest x-ray films, and kidney function was nOrma 
as estimated by c,reatinine c,iearance and urinalysis. 
Normotensive control subjects. The hypertensive men 
were compared with 51 healthy white men, all 50 years old; 
also recruited from the Oslo Study of Cardiovascular 
Diseases.’ Six to 10 years prior to the present investigation, 
their blood pressure averaged 124 I g/78 i 1 mm Hg, and 
later their blood pressure remained below 140/90 mm Hg. 
Table I shows the characteristics of these men at the t,ime 
of the present study. These men also had normal ocular 
fundi, ECGs, chest x-ray films, and kidney function was 
normal as estimated by creatinine clearance and urinalysis. 
Protocol. The study was approved by the Ethics Com- 
mittee of LJllevaal Hospital, University of Oslo. Informed 
consent was obtained from patients and cont.rol subjects. 
All subjects were outpatients and had regular daily em- 
ployment. For 6 to IO years they had been familiar with 
clinical examination, blood pressure recording, and blood 
sampling. None were addicted to alcohol or were taking any 
drugs, and they abstained f’rom alcohol for at least 2 days 
before blood sampling. The examinations were carried out 
between 8 and 9 AM following overnight fasting without in- 
take of fluid, food, nicotine, or caffeine after 12 AM. They 
were permitted to drink one glass c~f water in the morning 
before examination. Only one subject was examined each 
day, and all by the same physician. Hypertensive and nor- 
motensive subjects were examined in a random order. Im- 
mediately preceding the examination, a X-hour urine 
specimen was collected for urinalysis and determination of 
creatinine and electrolytes. 
Patients and controls rested supine for 30 minutes in a 
quiet room in the presence of t,he examining physician only. 
The room temperature was 20’ C. After this supine resting 
period, systolic and fifth phase diastolic blood pressure 
were measured as the average of two readings with a mer- 
cury sphygmomanometer. The heart rate was counted for 
1 minute. Immediately thereafter, 5 ml of venous blood for 
catecholamines was drawn from the median cubital vein 
with a 2Lgauge needle, and 5 ml of arterial blood for cat.- 
echolamines was obtained hy puncture of the femoral ar- 
tery with a hypodermic Z-gauge needle (this was hare11 
felt by the subjects). 
Blood was drawn into polypropylene syringes and was 
immediately transferred to ice-chilled tubes with glu- 
tathione and ethyleneglycol-bis-(@-aminoethylether)- 
N,N,N’,N’-tetraacetic acid (EGTA) and kept on melting 
ice. Within 1 hour. the samples were centrifuged at 4“ C, 
and the plasmas were frozen at -70” C. 
Analytical methods. Plasma norepinephrine and epi- 
nephrine were measured with a radioenzymatic technique 
according to that devised by Peuler and .Johnson,” ’ ds pre- 
viously reported.“’ For the two catecholamines. respec- 
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tively, this assay showed coefficients of variation of 9 % and 
13 % between single assays performed on different days in 
25 plasma samples. An equal number of hypertensive and 
normotensive subject plasma samples were assayed within 
each daily set-up. Creatinine and electrolytes were deter- 
mined on a Technicon sequential multiple analyzer (SMA) 
12/60 AutoAnalyzer (Technicon Instruments Corp., Tar- 
rytown, N.Y.). The technicians performing the assays were 
unaware of the patients’ blood pressure status. 
Statistical methods. The data were analyzed with the 
“MIDAS” statistical package on the University of Michi- 
gan’s IBM 3090-6003 computer (IBM Corp., Health In- 
dustry Marketing Division, Atlanta, Ga.). A two-tailed 
Student’s t test for unpaired samples and Pearson’s corre- 
lation coefficients were used for univariate analyses. For 
multivariate analyses, stepwise multiple regression analy- 
sis was applied for determining independent factors related 
to blood pressure. The level of statistical significance was 
set at p I 0.05. 
RESULTS 
Blood pressure, heart rate, body weight, electrolyte 
excretion, and creatinine clearance. Mean blood pres- 
sure was 30% higher in the hypertensive group than 
in the normotensive group following 30 minutes of 
supine rest (Table I), while resting heart rate was 
12% (p < 0.01) higher in the hypertensive group. 
Body mass index was 9% (p < 0.001) higher in the 
hypertensive group, while there was no statistical 
difference in the 24-hour urinary excretion of sodium 
and potassium or in creatinine clearance. 
Plasma catecholamines. Plasma norepinephrine in 
forearm venous blood averaged 346 + 22 pg/ml in the 
hypertensive group versus 303 + 11 pg/ml in the 
normotensive group (Fig. 1). This difference did not 
reach statistical significance (JJ > O.l), while the 
arterial plasma norepinephrine, 332 f 19 pg/ml, was 
significantly increased compared with 278 + 12 pg/ 
ml in the normotensive group @ < 0.03). Both arte- 
rial (116 k 10 pg/ml) and venous (52 + 4 pg/ml) 
plasma epinephrine concentrations in the hyperten- 
sive group (Fig. 1) were highly significantly elevated 
over the corresponding concentrations (74 + 4 and 
34 -+ 2 pg/ml, respectively) in the normotensive 
group (p < 0.001). 
Correlations with blood pressure. Mean blood pres- 
sure correlated positively and significantly with ar- 
terial plasma norepinephrine (r = 0.50, p < 0.001, 
Fig. 2), venous plasma norepinephrine (r = 0.47, 
p < .OOl), and arterial plasma epinephrine (r = 0.32, 
p < 0.02) in the hypertensive study group. Essential- 
ly the same correlation coefficients appeared between 
systolic and diastolic blood pressure and these plasma 
catecholamines. No significant correlation was found 
between blood pressure and heart rate, body mass 
index, electrolyte excretion, creatinine clearance, or 
venous plasma epinephrine. Stepwise multiple re- 




Fig. 1. Plasma catecholamines in antecubital venous 
blood (VENOUS) and in arterial blood (ARTERIAL) in 
normotensive (NT) and hypertensive (HT) groups. 
*p < 0.03 and ***p < 0.001 indicate significant differences 
between groups. 
gression analysis suggested that arterial plasma nor- 
epinephrine was the only significant independent 
explanatory variable of blood pressure in the hy- 
pertensive group (mean blood pressure: F = 0.51, 
t = 4.05, p = 0.0002; Table II). No variable cor- 
related with blood pressure in the normotensive 
group. 
Correlations between norepinephrine, epinephrine, 
heart rate and body mass index. In the hypertensive 
group, there were relatively strong positive correla- 
tions between norepinephrine, epinephrine, and 
heart rate; e.g., arterial norepinephrine correlated 
with arterial (r = 0.65, p < 0.001, Fig. 3) and venous 
epinephrine (r = 0.55, p < 0.001) and with heart rate 
(r = 0.58,~ < O.OOl).Botharterial (r = 0.30,~ < 0.03) 
and venous (r = 0.39, p < 0.003) epinephrine corre- 
lated with heart rate. In this group, arterial plasma 
epinephrine correlated negatively with body mass 
index (r = -0.27, p < 0.05). In addition, in the nor- 
motensive group, arterial norepinephrine correlated 
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Fig. 2. Correlation between arterial plasma norepinephrine concentration and mean arterial blood pres- 
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Table II. Cumulative multiple correlation and r2 coeffi- 
cients (amount of variability in mean blood pressure 
explained) when mean blood pressure is considered to be 









Arterial norepinephrine 0.5068* 0.2568* 
Urinary potassium excretion 0.5270 0.2777 
Venous epinephrine 0.5453 0.2974 
Ejody height 0.5585 0.3120 
Urinary sodium excretion 0.5633 0.3173 
Creatinine clearance 0.5661 0.3205 
Venous norepinephrine 0.5677 0.3222 
Arterial epinephrine 0.5690 0.3237 
Heart rate 0.5697 0.3245 
Body weight 0.5697 0.3245 
*p = 0.0002. 
positively with venous epinephrine (r = 0.33, 
p < 0.02) and heart rate (r = 0.38, p < 0.01). 
DISCUSSION 
The present study shows that plasma norepineph- 
rine correlates positively with blood pressure in 50- 
year-old men with never-treated, established essen- 
tial hypertension. A highly significant correlation was 
seen with plasma norepinephrine in both peripheral 
venous and arterial blood. However, only arterial 
concentrations were significantly elevated compared 
with those in a normotensive control group. Although 
plasma epinephrine, heart rate, and body weight 
were significantly increased in the hypertensive 
group, stepwise multiple regression analysis showed 
that arterial plasma norepinephrine was the only 
significant independent explanatory variable of the 
high blood pressure in the hypertensive group. 
Plasma norepinephrine is derived by overspill 
from the sympathetic nerve endings. An increased 
level of plasma norepinephrine does not necessarily 
imply increased sympathetic tone, because changes 
in neuronal reuptake, or clearance, may also be 
responsible. I1 Plasma norepinephrine represents only 
a small fraction of the amount released, and release 
of norepinephrine from many organs contributes to 
the level.12 Even in situations in which plasma nore- 
pinephrine adequately may reflect cardiovascular 
sympathetic tone, the overall effect on blood pres- 
sure, for example, may also depend on such factors as 
receptor sensitivity and affinity, amount of available 
receptors, and vascular reactivity. 
With all these limitations on the assessment of 
sympathetic nerve activity by plasma norepineph- 
rine concentration, the present findings of a 19 % in- 
crease in arterial plasma norepinephrine in the hy- 
pertensive group and a large overlap between the two 
groups does not seem impressive. Therefore a factor 
more important than a moderate hypertensive-nor- 
motensive difference in plasma concentration may be 
a positive correlation between plasma norepineph- 
rine and blood pressure. In our set of variables, 
plasma norepinephrine measured in arterial blood 
was the only independent predictor of blood pressure 
in the hypertensive group by stepwise multiple 
regression analysis (r g 0.51); i.e., 25% of variability 
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Fig. 3. Correlation between arterial plasma epinephrine concentration and arterial plasma norepineph- 
rine concentration in the hypertensive group. 
in blood pressure is explained by arterial norepineph- 
rine. This correlation supports, but does not prove, a 
causal relationship between the activity of the sym- 
pathetic nervous system and high blood pressure. 
As reviewed by Julius et al.,13 a positive correlation 
between plasma norepinephrine and blood pressure 
has been found in several but not in all 
studies of plasma norepinephrine in essential hyper- 
tension, regardless of the actual plasma norepineph- 
rine level. However, in all these studies reviewed,13 
the correlation has been estimated on the basis of 
measurement of plasma norepinephrine in periph- 
eral venous blood. An increased level of norepineph- 
rine in hypertension may predominantly reflect in- 
creased sympathetic tone to the heart and kidneys.5 
Muscle tissue contributes to approximately 50% of 
plasma norepinephrine in peripheral venous blood1 
and sympathetic tone to muscle tissue3 seems to be 
unchanged in essential hypertension. These limita- 
tions of norepinephrine in antecubital venous blood 
compared with venous effluents from the heart or 
kidneys or of norepinephrine in atria1 and arterial 
blood may partly or fully explain conflicting results 
concerning the correlation between plasma norepi- 
nephrine and blood pressure.13 
The correlation between arterial plasma norepi- 
nephrine and blood pressure in the hypertensive 
group only was not caused by a wider range of blood 
pressure in the hypertensive group (43 mm Hg for 
mean blood pressure) compared with that in the nor- 
motensive group (39 mm Hg). Most likely the corre- 
lation was caused by raised sympathetic tone to such 
organs as the heart and kidneys, with higher blood 
pressure in the hypertensive group.5 In addition, the 
reactivity for a given plasma concentration may be 
higher with higher blood pressure, as found in 
studies of norepinephrine infusion in essential 
hypertension.l*-l7 Such increased vascular reactivity 
in essential hypertension may have been caused by 
increased a-adrenergic sensitivity,ia arteriolar struc- 
tural changes,ls or both. 
The present data support our hypothesis7 that 
measurements of arterial compared to peripheral 
venous plasma norepinephrine may be a more sensi- 
tive tool for the detection of hypertensive-normoten- 
sive differences in 50-year-old white men. The same 
may be true for 40-year-old hypertensive subjects 
from the same population,20 and for young women 
with preeclampsiacompared withnormotensive preg- 
nant women.21 Esler et a1.5 and Egan et a1.6 also found 
increased arterial plasma norepinephrine in age- 
matched studies, but did not report peripheral venous 
plasma norepinephrine. A study by Goldstein22 show- 
ing both raised arterial and peripheral venous nor- 
epinephrine may, however, be invalid, since the pa- 
tients were on average 10 years older than the control 
subjects and plasma norepinephrine increases with 
age. 23 In addition, antihypertensive medication was 
discontinued only 2 weeks before the study22 and pa- 
tients and controls were not recruited from the same 
population.22 
Plasma epinephrine was 57% and 53% increased 
in arterial and venous blood in the hypertensive 
group, respectively. However, despite these consid- 
erable increments, elevated plasma epinephrine lev- 
els were found not to be an independent predictor of 
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higher blood pressure within the hypertensive group. 
Since the first report of raised epinephrine in essen- 
tial hypertension, 24 the role of epinephrine in the 
pathogenesis of hypertension has been discussed, but 
far from clarified. One of the theories is that epi- 
nephrine may activate presynaptic &-adrenergic re- 
ceptors that facilitate norepinephrine release from 
sympathetic nerves, causing hypertension.25* 26 Along 
with this, a recent study27 showed that “stress” lev- 
els of epinephrine, achieved by infusion of epineph- 
rine for 6 hours, caused a delayed and protracted 
pressor effect in human volunteers. Another opinion 
is that epinephrine is involved in the “arousal reac- 
tion” or early hyperkinetic state of hypertension, 
which will later result in compensatory vasoconstric- 
tory responses and structural vascular changes.28 A 
considerable hypertensive-normotensive difference 
in plasma epinephrine could also be of significance 
for metabolic disturbances in hypertension, since 
physiologic epinephrine levels may be involved in the 
regulation of, for example, lipid and lipoprotein 
metabolism,2g-31 glucose metabolism,“” and blood 
platelet function.30, 33 
In the hypertensive group, we found strong posi- 
tive correlations between increased norepinephrine, 
epinephrine, and heart rate. Increased heart rate in 
essential hypertension may be caused by an increase 
of sympathetic tone, a decrease of parasympathetic 
tone, or by both.34 If another pathophysiologic mech- 
anism other than altered autonomic function was 
operating, cardiac frequency would have been un- 
changed or even depressed by activated baroreflexes. 
Positive correlations may indicate covariation with- 
out causative relationship, i.e., both the noradrener- 
gic and adrenergic divisions of the sympathetic ner- 
vous system may be activated in hypertension. On 
the other hand, a strong correlation between plasma 
epinephrine and norepinephrine in the hypertensive 
group (r = 0.65) may indicate that plasma epineph- 
rine is involved in a process regulating the release of 
norepinephrine to plasma, such as stimulation of pre- 
synaptic fi-adrenergic receptors.25, 26 
Our hypertensive group had 9 % higher body mass 
index than the normotensive group, but this does not 
seem to be the cause of the increased sympathetic 
tone in the hypertensive group. Thus plasma epi- 
nephrine showed a weak but significant negative 
correlation with body mass index (F = -0.27) in the 
hypertensive group. In a recent report,35 a negative 
correlation between plasma catecholamines and per- 
cent body fat was explained as a mechanism pro- 
moting excessive storage of energy by decreasing 
sympathetic activity. If this holds true, even larger 
hypertensive-normotensivedifferencesinplasmacat- 
echolamines could be expected in studies with groups 
precisely matched for body mass. 
Mental stress may more easily create “arousal” 
with enhanced neurogenic activity of the type asso- 
ciated with the defense reaction in the hypertensive 
compared with the normotensive subjects.36 Merely 
the awareness of hypertension per se37 may increase 
blood pressure and create “arousal” in young subjects 
in connection with a provocative maneuver such as a 
cold pressor test. Along with this, Ibsen et al.3s found 
no difference in plasma catecholamine levels between 
hypertensive and normotensive 40-year-old men 
when the hypertensive individuals were unaware of 
their high blood pressure. However, only peripheral 
venous and not arterial plasma catecholamines were 
measured by Ibsen et al. 38 On the other hand, given 
this background of susceptibility of arousal in the 
hypertensive subjects (at least in those who are aware 
of their high blood pressure3”, 37), the act of arterial 
blood sampling per se, either by direct puncture as in 
the present and in a previous study,21 or by use of an 
indwelling catheter’“, 20. 22 or even central venous 
catheters introduced into the heart and kidneys,” 
may induce an arousal reaction and raise the plasma 
catecholamines. Whether arterial plasma catechola- 
mines are increased in hypertensive subjects unaware 
of their high blood pressure has yet to be determined. 
In conclusion, in a group of white men, all 50 years 
of age, with never-treated, established essential hy- 
pertension, we found that arterial plasma norepi- 
nephrine significantly correlated positively with 
blood pressure. Arterial plasma norepinephrine was 
the only significant independent predictor of blood 
pressure in the hypertensive group, in spite of the fact 
that plasma epinephrine, heart rate, and body mass 
index showed larger hypertensive-normotensive dif- 
ferences than did plasma norepinephrine. 
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